[go: up one dir, main page]

AU2015902358A0 - Treatment of inflammatory disease - Google Patents

Treatment of inflammatory disease

Info

Publication number
AU2015902358A0
AU2015902358A0 AU2015902358A AU2015902358A AU2015902358A0 AU 2015902358 A0 AU2015902358 A0 AU 2015902358A0 AU 2015902358 A AU2015902358 A AU 2015902358A AU 2015902358 A AU2015902358 A AU 2015902358A AU 2015902358 A0 AU2015902358 A0 AU 2015902358A0
Authority
AU
Australia
Prior art keywords
treatment
inflammatory disease
inflammatory
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015902358A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QIMR Berghofer Medical Research Institute
Original Assignee
Queensland Institute of Medical Research QIMR
Filing date
Publication date
Application filed by Queensland Institute of Medical Research QIMR filed Critical Queensland Institute of Medical Research QIMR
Publication of AU2015902358A0 publication Critical patent/AU2015902358A0/en
Priority to PCT/AU2016/050522 priority Critical patent/WO2016201528A1/en
Abandoned legal-status Critical Current

Links

AU2015902358A 2015-06-19 2015-06-19 Treatment of inflammatory disease Abandoned AU2015902358A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2016/050522 WO2016201528A1 (en) 2015-06-19 2016-06-20 Treatment of inflammation and/or cancer

Publications (1)

Publication Number Publication Date
AU2015902358A0 true AU2015902358A0 (en) 2015-07-09

Family

ID=

Similar Documents

Publication Publication Date Title
IL253945A0 (en) Kdm1a inhibitors for the treatment of disease
EP3256113A4 (en) Treatment of hypoparathyroidism
EP3122414A4 (en) Venous disease treatment
IL259281B (en) Bipyrazolyl derivatives useful for the treatment of autoimmune diseases
EP3160405A4 (en) Treatment of the ear
RS63231B1 (en) Quinoline derivatives for the treatment of inflammatory diseases
EP3157565A4 (en) Treatment of polybacterials infections
IL257561A (en) Methods of treating inflammatory diseases
IL253118A0 (en) Methods of treating inflammatory diseases
EP3340974A4 (en) Methods for treatment of diseases
GB201721287D0 (en) Treatment for inflammatory disease
EP3229813A4 (en) Treatment of hmgb1-mediated inflammation
EP3285767B8 (en) Treatment of pain
EP3297619A4 (en) Therapeutic uses of l-4-chlorokynurenine
EP3145931A4 (en) Treatment of autoimmune disease
GB201515244D0 (en) Treatment of inflammatory disease or condition
EP3182980A4 (en) Treatment of glycosylation deficiency diseases
EP3110455A4 (en) Treatment of resistant lesions
EP3242662A4 (en) Treatment of filarial diseases
EP3271017A4 (en) Treatment of skin conditions
EP3193935A4 (en) Treatment of fibrotic diseases
HK40056903B (en) Methods for treatment of diseases
AU2015902358A0 (en) Treatment of inflammatory disease
HK40090812A (en) Treatment of mitochondrial diseases
HK40101628A (en) Quinoline derivatives for the treatment of inflammatory diseases